These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 3189794

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
    Larsson LI, Moody AJ.
    J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Proglucagon processing in porcine and human pancreas.
    Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Orskov C.
    J Biol Chem; 1994 Jul 22; 269(29):18827-33. PubMed ID: 8034635
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Glicentin carboxyl-terminal specific antiserum].
    Yanaihara C, Matsumoto T, Yamamoto E, Mochizuki T, Yanaihara N.
    Horumon To Rinsho; 1982 Nov 22; 30(11):1257-61. PubMed ID: 6186422
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Proglucagon processing in islet and intestinal cell lines.
    Tucker JD, Dhanvantari S, Brubaker PL.
    Regul Pept; 1996 Apr 09; 62(1):29-35. PubMed ID: 8738879
    [Abstract] [Full Text] [Related]

  • 34. Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut.
    Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz TW, Sundler F.
    Regul Pept; 1984 Jul 09; 8(4):261-6. PubMed ID: 6548568
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characterization of binding sites for oxyntomodulin on a somatostatin-secreting cell line (RIN T3).
    Gros L, Demirpence E, Jarrousse C, Kervran A, Bataille D.
    Endocrinology; 1992 Mar 09; 130(3):1263-70. PubMed ID: 1371446
    [Abstract] [Full Text] [Related]

  • 37. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
    Munck A, Kervran A, Marie JC, Bataille D, Rosselin G.
    Peptides; 1984 Mar 09; 5(3):553-61. PubMed ID: 6473171
    [Abstract] [Full Text] [Related]

  • 38. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
    Dhanvantari S, Brubaker PL.
    Endocrinology; 1998 Apr 09; 139(4):1630-7. PubMed ID: 9528943
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.